Pfizer stock traded down Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat. Please watch the video at Investors.com - How To Buy Stocks ...

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

Both of Genzyme's products ... prevalent among the group of lysosomal storage disorders, which have been a historic focus for Genzyme in Cambridge, Massachusetts. This is Pfizer's first move ...

Representative Julie Johnson (D-Texas) recently sold shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 ...

Valued at a market cap of $152.2 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company ... company's extensive portfolio encompasses products like Eliquis, Comirnaty, and Paxlovid ...

The past year has been all about delivering the COVID-19 vaccine, but there's strong revenue growth from the rest of Pfizer's lineup as well. Pfizer (PFE) discovers, develops, manufactures ...

UBS Group lowered their price target on Pfizer from $31.00 to $29.00 ... distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers ...

Angela Hwang is a member of Pfizer’s executive team and the chief commercial officer and president of Pfizer’s global biopharmaceuticals ... medicines and products to patients.

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... and sale and distribution of related products worldwide. The biopharmaceutical isn’t generating the massive growth ...

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products ...